Literature DB >> 17919174

Unexpected functional consequences of xenogeneic transgene expression in beta-cells of NOD mice.

E H Leiter1, P Reifsnyder, J Driver, S Kamdar, C Choisy-Rossi, D V Serreze, M Hara, A Chervonsky.   

Abstract

We describe unexpected alterations in the non-obese diabetic (NOD/Lt) mouse model of type 1 diabetes (T1D) following forced beta-cell expression of non-mammalian genes ligated to an insulin promoter sequence. These include the jellyfish green fluorescent protein (GFP), useful for beta-cell identification, and the bacteriophage P1 Cre recombinase, necessary for beta cell-specific ablation of a gene using a Cre-loxP system. Homozygous expression of GFP, driven by the mouse insulin 1 gene promoter (MIP-GFP) in a single transgenic line of NOD mice, produced T1D in postnatal mice that was not associated with insulitis, but rather beta cell-depleted islets. Hemizygous transgene expression suppressed spontaneous autoimmune T1D in females, and produced a male glucose intolerance syndrome associated with age-dependent declines in plasma insulin content. Among lines of transgenic NOD/Lt mice expressing Cre recombinase driven by the rat insulin 2 promoter (RIP-Cre), high, non-mosaic expression correlated with suppressed T1D development. These findings emphasize the need for careful characterization of genetically manipulated NOD mouse stocks to insure that model characteristics have not been compromised.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17919174     DOI: 10.1111/j.1463-1326.2007.00770.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  9 in total

1.  Detection of β cell death in diabetes using differentially methylated circulating DNA.

Authors:  Eitan M Akirav; Jasmin Lebastchi; Eva M Galvan; Octavian Henegariu; Michael Akirav; Vitaly Ablamunits; Paul M Lizardi; Kevan C Herold
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-09       Impact factor: 11.205

Review 2.  Pancreas-specific Cre driver lines and considerations for their prudent use.

Authors:  Mark A Magnuson; Anna B Osipovich
Journal:  Cell Metab       Date:  2013-07-02       Impact factor: 27.287

3.  Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues.

Authors:  Kristin Melli; Rachel S Friedman; Ashley E Martin; Erik B Finger; Gang Miao; Gregory L Szot; Matthew F Krummel; Qizhi Tang
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  Genetic and Pharmacologic Models for Type 1 Diabetes.

Authors:  Edward H Leiter; Andrew Schile
Journal:  Curr Protoc Mouse Biol       Date:  2013-03-01

5.  Cytotoxic mechanisms employed by mouse T cells to destroy pancreatic β-cells.

Authors:  Vineeth Varanasi; Lia Avanesyan; Desiree M Schumann; Alexander V Chervonsky
Journal:  Diabetes       Date:  2012-07-06       Impact factor: 9.461

6.  Phenotypic Characterization of MIP-CreERT1Lphi Mice With Transgene-Driven Islet Expression of Human Growth Hormone.

Authors:  Daniel Oropeza; Nathalie Jouvet; Lionel Budry; Jonathan E Campbell; Khalil Bouyakdan; Julie Lacombe; Gabrielle Perron; Valerie Bergeron; Joshua C Neuman; Harpreet K Brar; Rachel J Fenske; Clemence Meunier; Sarah Sczelecki; Michelle E Kimple; Daniel J Drucker; Robert A Screaton; Vincent Poitout; Mathieu Ferron; Thierry Alquier; Jennifer L Estall
Journal:  Diabetes       Date:  2015-07-07       Impact factor: 9.461

Review 7.  Suppressors of Cytokine Signaling in Sickness and in Health of Pancreatic β-Cells.

Authors:  Cheng Ye; John P Driver
Journal:  Front Immunol       Date:  2016-05-09       Impact factor: 7.561

8.  Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes.

Authors:  James Dooley; Lei Tian; Susann Schonefeldt; Viviane Delghingaro-Augusto; Josselyn E Garcia-Perez; Emanuela Pasciuto; Daniele Di Marino; Edward J Carr; Nikolay Oskolkov; Valeriya Lyssenko; Dean Franckaert; Vasiliki Lagou; Lut Overbergh; Jonathan Vandenbussche; Joke Allemeersch; Genevieve Chabot-Roy; Jane E Dahlstrom; D Ross Laybutt; Nikolai Petrovsky; Luis Socha; Kris Gevaert; Anton M Jetten; Diether Lambrechts; Michelle A Linterman; Chris C Goodnow; Christopher J Nolan; Sylvie Lesage; Susan M Schlenner; Adrian Liston
Journal:  Nat Genet       Date:  2016-03-21       Impact factor: 38.330

9.  12-Lipoxygenase governs the innate immune pathogenesis of islet inflammation and autoimmune diabetes.

Authors:  Abhishek Kulkarni; Annie R Pineros; Melissa A Walsh; Isabel Casimiro; Sara Ibrahim; Marimar Hernandez-Perez; Kara S Orr; Lindsey Glenn; Jerry L Nadler; Margaret A Morris; Sarah A Tersey; Raghavendra G Mirmira; Ryan M Anderson
Journal:  JCI Insight       Date:  2021-07-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.